AN2 Therapeutics, Inc. (ANTX)
5.69
-0.29
(-4.85%)
USD |
NASDAQ |
Sep 09, 13:39
AN2 Therapeutics Total Assets (Quarterly) : 81.68M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 81.68M |
| March 31, 2026 | 87.49M |
| December 31, 2025 | 61.95M |
| September 30, 2025 | 67.24M |
| June 30, 2025 | 75.82M |
| March 31, 2025 | 81.34M |
| December 31, 2024 | 92.09M |
| September 30, 2024 | 97.69M |
| June 30, 2024 | 108.48M |
| March 31, 2024 | 121.26M |
| Date | Value |
|---|---|
| December 31, 2023 | 138.74M |
| September 30, 2023 | 153.81M |
| June 30, 2023 | 98.93M |
| March 31, 2023 | 91.08M |
| December 31, 2022 | 102.56M |
| September 30, 2022 | 110.01M |
| June 30, 2022 | 120.02M |
| March 31, 2022 | 120.50M |
| December 31, 2021 | 65.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.755M |
| Shareholders Equity (Quarterly) | 75.92M |
| Current Ratio | 14.32 |